-
Galloway accuser could not foresee publishing-sector fallout, lawyer argues
-
أزمة الإسكان في البرتغال: تصاعد الأسعار يعمق الانقسامات السياسية حول الحريات
-
No. 22 UCLA defeats No. 5 Arizona 84-75 despite Kharchenkov's 38 points
-
New York City Center revives In the Heights as a timely community story
-
Vessel operator seeks witnesses after Vancouver grounding
-
Godzilla Minus Zero shifts focus toward postwar human drama
-
US Air Force deploys F-16 fighters to remote Aleutian base for readiness drill
-
Mehbooba Mufti urges dialogue and renewed Central Asia links for Kashmir
-
Bezos grant helps Seattle nonprofit move thousands of families toward housing
-
Seacliff Healthcare Seeks Specialist GP in Thirroul
-
Shrini Srivastava joins crew of Varanasi-Delhi Vande Bharat Sleeper service
-
US stocks fall before midterm Election Day as technology shares weaken
-
Nearly Half of Australian Workers Overqualified, Survey Finds
-
BLS Polymers makes strong market debut at ₹248 per share
-
RBI eases export-declaration compliance for individual service exporters
-
Petrol and diesel prices remain broadly steady across major Indian cities
-
India proposes more import entry points for drugs and medical devices
-
Reliance shares remain in focus after near-12% surge
-
Derek Tierney Outlines Ten-Year Strategy for National Digital Health System
-
2026 Arizona Midterms: Key Races, Ballot Measures, and Voter Deadlines
-
NBC’s Steve Kornacki Reveals Tech Habits Ahead of Midterm Elections
-
Coal India prepares possible $1 billion Mahanadi Coalfields listing
-
India and Israel oppose UN draft on regional conventional arms control
-
Julia Stiles and Ezra Sosa Share Emotional Farewell After 'DWTS' Elimination
-
BLS Polymers shares open 65.3% above IPO price
-
US Buildings Threatened by Wildfires Could Triple by 2060
-
Capital-markets shares rally as Motilal Oswal and Angel One lead gains
-
Why Pregnancy Cost Estimates Fail: A Family’s $9,000 Surprise
-
Latino Voters Defy ICE Fears, Turn Out in Record Numbers for Midterms
-
US Strikes Iranian Targets in Strait of Hormuz Ahead of Midterms
-
ITC shares rise as analysts anticipate gradual cigarette-business recovery
-
Brodeur’s Overtime Goal Secures Bethlehem’s Second Consecutive Sectional Title
-
Reliance rally puts historical one-year return pattern in focus
-
Rare 1970 Plymouth ‘Cuda 426 Hemi Listed for $400,000
-
Kuwait edges Oman 1-0 in veterans Gulf Cup in Doha
-
The Digital Burden: Why Instant Messaging Feels Like a Full-Time Job
-
Saudi Aramco quarterly profit climbs 34.6% amid elevated oil prices
-
Alberta Tabled Controversial Riding Boundary Maps Amid Gerrymandering Accusations
-
Washington reports movement in Iran negotiations aimed at preventing escalation
-
Hong Kong court set to sentence activist Joshua Wong in security case
-
Korea’s Labor Share of GDP Hits Record Low Amid Semiconductor Boom
-
Australia raises benchmark rate to highest level in 18 years
-
littlefish and Halo Dot Partner to Replace Payment Terminals with SoftPOS
-
'The Remarried Empress' Cast Discusses Bringing Fantasy Royal Drama to Life
-
Kuwait inspectors destroy 115 kilograms of unverified meat in Farwaniya
-
Asian stocks retreat as AI worries outweigh steep oil-price drop
-
Egypt Accelerates Construction of 341km Sinai Railway Linking Arish and Taba
-
Hamad International Airport stages emergency drills during WATAN 2026
-
John Schneider Admits Owes Millions in 'Dukes of Hazzard' Divorce Battle
-
Global failure to punish attacks leaves journalists at continuing risk
Maresca insists Chelsea 'trust' Mudryk despite failed drugs test
Chelsea boss Enzo Maresca believes Mykhailo Mudryk did not knowingly take a banned supplement.
The Blues said Tuesday they were notified by the Football Association of an "adverse finding" in a urine sample provided by the 23-year-old Ukrainian winger.
Mudryk said in an Instagram post the results of his 'A' sample had come as a "complete shock" and insisted he had not intentionally taken a banned substance.
"We trust Misha," said Maresca on Wednesday.
"When this kind of thing happens you need to support your player in all aspects.
"Misha is a Chelsea player, it's my duty to be in contact with him. Me, the club, his team-mates, we are all there.
"Trust means we believe Misha."
Athletes are warned on the UK Anti-Doping (UKAD) website that they face a ban of four years if it is found a banned substance was taken intentionally.
If the violation involved a specified substance or a contaminated product, and the athlete can demonstrate they had no significant fault, ineligibility may range from two years to a reprimand, depending on the level of fault.
Mudryk has made 15 appearances for Chelsea this season and last played in a 2-0 win at German side Heidenheim in the Conference League on November 28, in which he scored his third goal of the season.
He has not featured in the past five matches in all competitions.
"I think he's going to come back, the only thing is we don't know when," said Maresca.
He added: "Any player in the world when this happens, they need support. No matter if he's 20 or 30, no matter if he’s English or Italian or Ukrainian. When this kind of things happens, we all need support. It's not about his age or his country.
"With Misha it is exactly the same. I'm there to try to help him in anything he needs because in this moment it's normal that he’s going need help from the club, from me, from his team-mates, and we are all there to try to support.”
Mudryk joined Chelsea for a reported £88.5 million ($112 million) from Ukrainian club Shakhtar Donetsk in January 2023.
Maresca's side are second in the Premier League and top the European Conference League table ahead of their match against Irish club Shamrock Rovers on Thursday.
R.Halabi--SF-PST